Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989
- PMID: 8256208
Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989
Abstract
Background: Multivariate analyses in papillary thyroid carcinoma (PTC) have shown that age, tumor size, local invasion and distant metastasis are independent predictive variables. This study attempted to define a reliable prognostic scoring system for predicting PTC mortality rates with 15 candidate variables that included completeness of primary tumor resection but excluded histologic grade and DNA ploidy.
Methods: The study group comprised 1779 patients with PTC (followed up for > 26,000 patient-years), divided by treatment dates into 1940 to 1964 (n = 764) and 1965 to 1989 (n = 1015). Cox model analysis and stepwise variable selection led to a prognostic model initially derived from the training set (n = 764). The initial prognostic score was thereafter validated externally with the later (1965 to 1989) "test" data set.
Results: The final model included five variables abbreviated by metastasis, age, completeness of resection, invasion, and size (MACIS). The final prognostic score was defined as MACIS = 3.1 (if aged < or = 39 years) or 0.08 x age (if aged > or = 40 years), + 0.3 x tumor size (in centimeters), +1 (if incompletely resected), +1 (if locally invasive), +3 (if distant metastases present). Twenty-year cause-specific survival rates for patients with MACIS less than 6, 6 to 6.99, 7 to 7.99, and 8+ were 99%, 89%, 56%, and 24%, respectively (p < 0.0001).
Conclusions: Because the five variables needed for MACIS scoring are readily available after primary operation, such a prognostic system could have widespread applicability in assessment of PTC.
Similar articles
-
Papillary thyroid carcinoma in Denmark, 1996-2008: outcome and evaluation of established prognostic scoring systems in a prospective national cohort.Thyroid. 2015 Jan;25(1):78-84. doi: 10.1089/thy.2014.0294. Thyroid. 2015. PMID: 25368981
-
Staging systems for papillary thyroid carcinoma: a review and comparison.Ann Surg. 2007 Mar;245(3):366-78. doi: 10.1097/01.sla.0000250445.92336.2a. Ann Surg. 2007. PMID: 17435543 Free PMC article. Review.
-
Optimizing the treatment of AMES high-risk papillary thyroid carcinoma.World J Surg. 2004 Nov;28(11):1103-9. doi: 10.1007/s00268-004-7420-6. World J Surg. 2004. PMID: 15490070
-
Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients.World J Surg. 2002 Aug;26(8):879-85. doi: 10.1007/s00268-002-6612-1. Epub 2002 May 21. World J Surg. 2002. PMID: 12016468
-
[Survival potentials of patients with papillary carcinoma of the thyroid gland in Hungary].Orv Hetil. 1996 May 19;137(20):1067-78. Orv Hetil. 1996. PMID: 8657418 Review. Hungarian.
Cited by
-
Discriminating Interpatient Variabilities of RAS Gene Variants for Precision Detection of Thyroid Cancer.JAMA Netw Open. 2024 May 1;7(5):e2411919. doi: 10.1001/jamanetworkopen.2024.11919. JAMA Netw Open. 2024. PMID: 38758552 Free PMC article.
-
New strategy for intraoperative phonosurgical management of recurrent laryngeal nerve infiltrated by thyroid carcinoma.Langenbecks Arch Surg. 2024 Apr 27;409(1):138. doi: 10.1007/s00423-024-03323-x. Langenbecks Arch Surg. 2024. PMID: 38676783 Free PMC article.
-
Feasibility of active surveillance in patients with clinically T1b papillary thyroid carcinoma ≤1.5 cm in preoperative ultrasonography: MASTER study.Eur Thyroid J. 2024 Apr 18;13(2):e230258. doi: 10.1530/ETJ-23-0258. Print 2024 Apr 1. Eur Thyroid J. 2024. PMID: 38484463 Free PMC article.
-
The genomic and evolutionary landscapes of anaplastic thyroid carcinoma.Cell Rep. 2024 Mar 26;43(3):113826. doi: 10.1016/j.celrep.2024.113826. Epub 2024 Feb 26. Cell Rep. 2024. PMID: 38412093 Free PMC article.
-
Improvement in Central Neck Dissection Quality in Thyroid Cancer by Use of Tissue Autofluorescence.Cancers (Basel). 2024 Jan 6;16(2):258. doi: 10.3390/cancers16020258. Cancers (Basel). 2024. PMID: 38254749 Free PMC article.